Phapros Tbk PT (PEHA) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.051x

Based on the latest financial reports, Phapros Tbk PT (PEHA) has a cash flow conversion efficiency ratio of 0.051x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp20.00 Billion ≈ $1.17 Million USD) by net assets (Rp395.57 Billion ≈ $23.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Phapros Tbk PT - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Phapros Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Phapros Tbk PT for a breakdown of total debt and financial obligations.

Phapros Tbk PT Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Phapros Tbk PT ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Genmin Ltd AU:GEN	-0.213x
CADOGAN ENERGY SOLUTIONS F:CPD	N/A
Way 2 Vat Ltd AU:W2V	-1.805x
Samil Co.Ltd KQ:032280	0.015x
West International AB ST:WPAY	0.282x
Idomoo Ltd TA:IDMO	0.085x
Cheetah Holdings Bhd KLSE:7209	-0.096x
In8bio Inc NASDAQ:INAB	-0.267x

Annual Cash Flow Conversion Efficiency for Phapros Tbk PT (2013–2024)

The table below shows the annual cash flow conversion efficiency of Phapros Tbk PT from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Phapros Tbk PT market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Rp393.12 Billion ≈ $23.04 Million	Rp141.28 Billion ≈ $8.28 Million	0.359x	+2016.64%
2023-12-31	Rp770.33 Billion ≈ $45.14 Million	Rp-14.44 Billion ≈ $-846.35K	-0.019x	-151.56%
2022-12-31	Rp771.82 Billion ≈ $45.23 Million	Rp28.07 Billion ≈ $1.64 Million	0.036x	-85.81%
2021-12-31	Rp740.98 Billion ≈ $43.42 Million	Rp189.92 Billion ≈ $11.13 Million	0.256x	-26.81%
2020-12-31	Rp740.91 Billion ≈ $43.41 Million	Rp259.48 Billion ≈ $15.20 Million	0.350x	+11694.31%
2019-12-31	Rp821.61 Billion ≈ $48.14 Million	Rp-2.48 Billion ≈ $-145.42K	-0.003x	+96.86%
2018-12-31	Rp789.80 Billion ≈ $46.28 Million	Rp-75.91 Billion ≈ $-4.45 Million	-0.096x	-166.07%
2017-12-31	Rp701.39 Billion ≈ $41.10 Million	Rp102.03 Billion ≈ $5.98 Million	0.145x	-20.68%
2016-12-31	Rp622.08 Billion ≈ $36.45 Million	Rp114.08 Billion ≈ $6.68 Million	0.183x	+17.67%
2015-12-31	Rp449.72 Billion ≈ $26.35 Million	Rp70.09 Billion ≈ $4.11 Million	0.156x	-24.29%
2014-12-31	Rp408.25 Billion ≈ $23.92 Million	Rp84.04 Billion ≈ $4.92 Million	0.206x	+313.18%
2013-12-31	Rp391.40 Billion ≈ $22.93 Million	Rp19.50 Billion ≈ $1.14 Million	0.050x	--

About Phapros Tbk PT

JK:PEHA Indonesia Drug Manufacturers - Specialty & Generic

Market Cap

$14.67 Million

Rp250.32 Billion IDR

Market Cap Rank

#25910 Global

#582 in Indonesia

Share Price

Rp298.00

Change (1 day)

-0.67%

52-Week Range

Rp260.00 - Rp364.00

All Time High

Rp2996.89